198HO02100 MIURA

Print/PDF
Registration Name GO-FARM MIURA-ET
Registration Number HOITA019991486573
Primary NAAB Code 198HO02100
Secondary Code(s) 598HO02100
Status Inactive
Controller Name INTERMIZOO S.p.A. (198)
Date of Birth 5/26/2016
aAa 342516
DMS -
GFI 11.3%
Genetic Codes * TL TV TY TR TP TC TD TM TE
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T
Sire SANDY-VALLEY AFTERBURNER-ET
MGS MR LOOKOUT P ENFORCER-ET
Beta Casein A2A2
Kappa Casein AB
Beta Lactoglobulin AB
INDEXES
NM$ 192, 84% R CM$ 229
NM Percentile 24% FM$ 104
GTPI 2651 GM$ 231
PRODUCTION TRAITS
7429 Dtrs 1694 herds 0 % US 91% R
Milk -305 Fat, % 7 , +0.08%
SCS 2.88, 90% R Protein, % 16 , +0.10%
Feed Saved 61 , 54% R Milking Speed 7.2 , 64% R
Health & Fertility
Productive Life 1.2      89% R Mastitis -0.5      75% R
Heifer Livability 0.3       58% R Metritis 0.9      72% R
Livability 0.9      83% R D. Abom -0.3      74% R
DPR 2.6      89% R Ketosis 0.2      72% R
HCR 1.3      89% R R. Placenta 0.1      73% R
FSC 4.7      78% R Milk Fever 0.0      66% R
CCR 2.5      89% R
SCR -        -
DIA -0.5      43% R
RSP -0.1      52% R
Calving Traits
Sire CE 1.2      79% R 10417 Obs
Daughter CE 1.5      67% R 0 Obs, 3147 Dtrs
Sire SB 3.9      55% R 23081 Obs
Daughter SB 4.6      69% R 0 Obs, Dtrs
Gestation Length -0.4      97% R 429 Obs, 5850 Dtrs
Early First Calving 1.2      77% R 0 Obs, 0 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
2446 Dtrs 752 herds 90% R
PTA Type -0.41 UDC -0.96
HCC -0.01 BWC 0.07
FLC 0.23
Linear Traits
Stature -0.46
Short
Strength 0.39
Weak
Body Depth 0.77
Deep
Dairy Form 0.23
Open
Rump Angle -0.27
Flat
Thurl Width -0.32
Narrow
Rear Legs-Side View 0.20
Curved
Rear Legs-Rear View 0.17
Straight
Foot Angle -0.84
Low
Feet & Legs Score 0.17
High
F.U. Attachment -1.96
Weak
Rear Udder Height -0.76
Low
Rear Udder Width -0.57
Narrow
Udder Cleft 0.24
Strong
Udder Depth -1.76
Deep
Front Teat Placement 0.32
Close
Rear Teat Placement 0.02
Close
Teat Length 0.04
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO